These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33923668)

  • 1. Addressing Barriers to HIV Point-of-Care Testing in Community Pharmacies.
    McKeirnan K; Kherghehpoush S; Gladchuk A; Patterson S
    Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33923668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
    Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
    BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain.
    So E; Brands M; Suomala E; Ogden B; Riss J; Cernasev A; Schommer J
    Innov Pharm; 2019; 10(1):. PubMed ID: 34007531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of POCT for pharmacies to reduce risk and optimize access to care in HIV, the APPROACH study protocol: examining acceptability and feasibility.
    Kielly J; Kelly DV; Hughes C; Day K; Hancock S; Asghari S; Gahagan J; Marra C; Nguyen H
    Pilot Feasibility Stud; 2018; 4():59. PubMed ID: 30788134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' perspectives on HIV testing in community pharmacies.
    Ryder PT; Meyerson BE; Coy KC; von Hippel CD
    J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A state-level needs analysis of community pharmacy point-of-care testing.
    Gallimore CE; Porter AL; Barnett SG; Portillo E; Zorek JA
    J Am Pharm Assoc (2003); 2021; 61(3):e93-e98. PubMed ID: 33431252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training student pharmacists to facilitate human immunodeficiency virus point-of-care testing.
    Staudt AM; Draime JA; Deitschmann N; Norfolk M; Jenkins ZN
    Curr Pharm Teach Learn; 2020 Oct; 12(10):1245-1251. PubMed ID: 32739062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an accredited training program on implementation of point-of-care testing in community pharmacies.
    Smith MG; Rains L
    J Am Pharm Assoc (2003); 2020; 60(6):e140-e144. PubMed ID: 32448745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-led HIV and hepatitis C point-of-care testing and risk mitigation counseling in individuals experiencing homelessness.
    Kherghehpoush S; McKeirnan KC
    Explor Res Clin Soc Pharm; 2021 Mar; 1():100007. PubMed ID: 35479505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings.
    Min AC; Andres JL; Grover AB; Megherea O
    Health Promot Pract; 2020 Sep; 21(5):831-837. PubMed ID: 31257939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement.
    Hohmeier KC; McKeirnan K; Akers J; Klepser M; Klepser SA; Chen C; Klepser DG
    Implement Sci Commun; 2022 Jul; 3(1):77. PubMed ID: 35842688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
    Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
    J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics.
    Lecher SL; Shrestha RK; Botts LW; Alvarez J; Moore JH; Thomas V; Weidle PJ
    J Am Pharm Assoc (2003); 2015; 55(5):488-92. PubMed ID: 26359959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of community pharmacies in the HIV and HCV care continuum.
    Kherghehpoush S; McKeirnan KC
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100215. PubMed ID: 36938123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A feasibility study of community pharmacists performing depression screening services.
    O'Reilly CL; Wong E; Chen TF
    Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy.
    Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M
    J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist-provided rapid HIV testing in two community pharmacies.
    Darin KM; Klepser ME; Klepser DE; Klepser SA; Reeves A; Young M; Scarsi KK
    J Am Pharm Assoc (2003); 2015; 55(1):81-8. PubMed ID: 25415222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist testers in multidisciplinary health care team expand HIV point-of-care testing program.
    Sherman EM; Elrod S; Allen D; Eckardt P
    J Pharm Pract; 2014 Dec; 27(6):578-81. PubMed ID: 24326407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.